Evaluate the Efficacy, Safety and Tolerability of Fecal Microbiota Transfer for the Treatment of Patients With Nonalcoholic Steatohepatitis

PHASE2Not yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 1, 2024

Primary Completion Date

November 1, 2025

Study Completion Date

March 1, 2026

Conditions

Patients With Nonalcoholic Steatohepatitis

Interventions

DRUG

Group 1 or Experimental group

Capsules of fecal microbiota transplantation

OTHER

Group 2 or Control group

capsules of placebo

All Listed Sponsors

lead

Instituto de Investigación Marqués de Valdecilla

OTHER